Johnson & Johnson Stock Rises on Analyst Upgrade

Guggenheim raises price target on healthcare giant's shares

Apr. 8, 2026 at 8:53pm

Got story updates? Submit your updates here. ›

An extreme close-up of the heavy, industrial machinery and components that power Johnson & Johnson's global healthcare operations, rendered in a high-contrast, documentary-style visual metaphor for the company's financial security and institutional strength.The complex financial and operational infrastructure that underpins Johnson & Johnson's diverse healthcare businesses.New Brunswick Today

Shares of Johnson & Johnson (NYSE:JNJ) rose 1.1% on Wednesday after investment firm Guggenheim upgraded its price target on the stock from $240 to $244, maintaining a buy rating. The healthcare company's stock traded as high as $241.33 during the session.

Why it matters

Johnson & Johnson is one of the largest and most influential healthcare companies in the world, with a diverse portfolio spanning pharmaceuticals, medical devices, and consumer products. Analyst upgrades and price target increases can signal growing confidence in the company's future performance and outlook.

The details

Guggenheim cited the company's strong product pipeline and market position as reasons for the upgrade. Other analysts have also recently raised their price targets on Johnson & Johnson, with HSBC increasing its target to $280 and Wolfe Research boosting its target to $240.

  • The upgrade was announced on April 8, 2026.

The players

Johnson & Johnson

A multinational healthcare company that develops, manufactures, and markets a broad range of products across pharmaceuticals, medical devices, and consumer health.

Guggenheim

An investment firm that provides financial advisory and asset management services.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

The takeaway

The positive analyst sentiment around Johnson & Johnson reflects the company's strong market position and diversified business model, which have helped it weather industry challenges and maintain investor confidence.